The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
UIC researchers to develop new drugs to fight bioterrorism

The University of Illinois at Chicago College of Pharmacy has received a grant from the U.S. Department of Defense to develop new drugs to combat agents of bioterrorism.

The one-year, $880,000 grant will fund the college's new Institute for Advanced Pharmaceutical Sciences. The center will discover new and effective medicines to fight bioterrorism and assist the college in obtaining additional funding sources to develop medicines to fight other infectious and chronic diseases such as tuberculosis, cancer, neurodegenerative diseases and bipolar disorder.

"Anthrax has been identified by the Centers for Disease Control and Prevention as one of the most serious threats of bioterrorism, and UIC's College of Pharmacy has an extensive research program devoted to the discovery and development of antibiotics for the treatment of this and other infectious diseases," said Jerry Bauman, dean of the College of Pharmacy. "This grant will allow us to expand on our current studies."

UIC researchers will conduct four projects over the course of the year.

The projects entail the probing of novel sites in bacterial ribosomes for new antibiotic action; the development of aminocyclodextrins to block pore assembly by the anthrax pathogen in host tissues; rational development of new inhibitors of a key enzyme in fatty acid biosynthesis (Fab1) in many gram-positive and gram-negative bacteria; and the development and screening of natural products for their therapeutic potential against anthrax and other infectious agents such as Y. pestis, F. tularensis, Brucella spp, and Burkholderia spp.

Bauman will serve as director of the new center, with William Beck, professor and head of biopharmaceutical sciences, serving as deputy director. Researchers include Mike Johnson, professor and director of the UIC Center for Pharmaceutical Biotechnology; Andrew Mesecar, associate professor, Center for Pharmaceutical Biotechnology; Alexander Mankin, prof
'"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
6-Aug-2007


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UQ researchers discover some of the oldest forms of life
6. U of M researchers discover new method to combat HIV
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Physician-researchers often less successful in obtaining NIH funding
10. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
11. Cedars-Sinai researchers present new endocrine findings at 2 international conferences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UIC researchers develop new drugs fight bioterrorism

(Date:11/8/2009)...ire/ -- Pharmaceutical Research and Manufacturers ...on released the following statement regarding the ...pointed, but not surprised by today,s vote -- an u...ans as well as nearly half of the members of the U... bill. ,, "While well intentioned, the bill -- ...
(Date:11/8/2009)...Care Reform Bill ,, Critical legislation woul...ericans ,, BALTIMORE, Nov. 7 /PRNewswire-USNew...se of Representatives passed critical health care ...for seniors and end discrimination by insurance co...ffordable health coverage. ,, The Affordable He...
(Date:11/7/2009).../ -- The American Medical Association (AMA) proudl...Family Violence Prevention Fund, with the Citation...l policy-making meeting. The Citation for Disting...of Delegates bestows on a non-physician. ,, (...209/AMALOGO ) ,, "Ms. James has worked selfle...
(Date:11/7/2009)...sponsibility to vigorously oppose abortion in heal...HINGTON, Nov. 7 Amer...e following statement on the news that Cardinal Ju...fordable Health Care for America Act (H.R. 3962), ...r abortion is voted upon. ,, "Our Catholic bis...
(Date:11/7/2009)...rebel, expert says , , SATURDAY, Nov. 7 (H...badly if their parents expect them to, a new U.S. ...imply being realistic might actually contribute to...psychology professor at Wake Forest University and... release. "Negative expectations on the part of bo...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
(Date:11/6/2009)...wire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulleti...lanta-based, biopharmaceutical company developing ... Immunodeficiency Virus) and other infectious agen...al results and provided an operational update. ,...utive Officer commented, "We are pleased with our ...
(Date:11/6/2009)...PRNewswire/ -- , - Trial Will Compare NXL...tment of Multi-Resistant Staphylococcus Aureus (MR...armaceutical company focused on the discovery and,...ome the significant global,problem of microbial re...ral,antibacterial NXL103 (flopristin/linopristin),...
(Date:11/5/2009)... Helix BioPharma Corp. (...at its Phase II trial of Topical Interferon Alpha-...s completed patient enrollment, with the required ... The double-blind and placebo-controlled Phase II ...nd Sweden. Patients participating in the trial se...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 1Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 2Team24 News Article New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 52479 3Burner Balm Gets International Attention 52477 1Burner Balm Gets International Attention 52477 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 1Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 2Takeda Provides Update on the Investigational Fixed Dose Combination of alogliptin and ACTOS 28R 29 28pioglitazone HCl 29 4769 3
Other News:
...An inhaled anti-rejection drug can dramatically im...to a study conducted at the University of Pittsbur... at the University of Maryland in Baltimore. The r...2, 2006 edition of the New England Journal of Medi...
...Eating a very low-calorie yet nutritionally balanc...ction in members of an organization called the Cal...ton University School of Medicine in St. Louis fou... much younger people. The researchers report their...
The human body contains many metals, from the iron in hemoglobin to the calcium in bones. Other metals, usually in trace amounts, participate in many metabolic and degenerative processes. The recent i
...This month, the medical humanitarian organisation,...n initiative to help vulnerable people to access h...n why such a scheme is needed, while an editorial ...owards marginalised people.......Providing health ...
health news:Study shows inhaled medicine improves survival for lung transplant patients 2health news:Study shows inhaled medicine improves survival for lung transplant patients 3health news:Study shows inhaled medicine improves survival for lung transplant patients 4health news:Caloric restriction appears to prevent primary aging in the heart 2health news:Caloric restriction appears to prevent primary aging in the heart 3health news:Caloric restriction appears to prevent primary aging in the heart 4
...unces nationwide initiative to boost awareness of....arcolepsy Network announced today that it.is joini..."Wake Up to.Narcolepsy," an educational initiative...narcolepsy and its treatment. An estimated 125,00...
...em, N.C. -- Researchers at Wake Forest University ...to report the successful use of.magnetic resonance...n blood.vessels leading to the heart. This is the ...nd determine if they require treatment... M...
...nts may face an increased risk of depression as a ...pplies of estrogen, according to the.results of a ...pital, Boston. .."Dysphoria, insomnia, and hot fla...ancer treatment induced estrogen deficiency," says...
... 1999 -- America's growing use of depression-treat...epressants the biggest contributors to a.record-se...nt last year,.according to a study by the country'...press Scripts, Inc. ..Not everyone was hit by the...
health news:Narcolepsy network issues national 'wake up' call 2health news:Narcolepsy network issues national 'wake up' call 3health news:Wake Forest researchers develop new technique to diagnose narrowed heart,arteries 2health news:Breast cancer patients face increased depression 2health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 2health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 3health news:Depression-treating drugs lead record-setting pharmacy benefit cost rise -- Total increase lower when pharmacy benefit actively managed 4